Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christine A Pratilas
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
172 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Pediatric Hospital
San Juan, Puerto Rico
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Banner Children'S at Desert
Mesa, Arizona, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Naval Medical Center -San Diego
San Diego, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke'S Medical Center
Denver, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Broward Health Medical Center
Fort Lauderdale, Florida, United States
- Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Memorial Regional Hospital/joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Oct 2020
- Primary completion
- 31 Mar 2024
- Completion
- 30 Sept 2027
- Last update posted
- 27 May 2026
- Registered enrollment
- 5
- Registry id
- NCT04284774
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.